Indeed, Myc activation has been shown to occur in many lymphomas, e.g. those with plasmablastic morphology [11], motivating our search for additional markers to distinguish BL from high-grade DLBCL and to discern sub-types of BL. The gene discussed is MYC; the disease is Burkitt lymphoma.